Wearable Health Solutions (WHSI) 10-Q 14 Nov 22 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Sep. 30, 2022	Nov. 14, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--06-30
Entity File Number	000-56368
Entity Registrant Name	WEARABLE HEALTH SOLUTIONS, INC.
Entity Central Index Key	0001443089
Entity Tax Identification Number	26-3534190
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2901 W. Coast Highway
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Newport Beach
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92663
City Area Code	949
Local Phone Number	270-7460
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,531,592,608

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Current Assets
Cash and cash equivalents	$ 255,904	$ 70,505
Accounts receivable, net	16,657	0
Due from related parties (See Footnote 11)	0	155,800
Accounts receivable, other	2,000	2,000
Inventory	41,196	7,064
Prepaid Inventory	18,522	62,040
Prepaid expenses	1,325	0
Total Current Assets	335,604	297,409
Property and Equipment:
Property and equipment (net of depreciation of $10,893 and $8,349, respectively)	48,549	41,651
Total Property, Plant and Equipment	48,549	41,651
Right-of-use assets	42,001	0
Total Assets	426,154	339,060
LIABILITIES and SHAREHOLDERS' DEFICIT
COMMITMENTS AND CONTINGENCIES (Note 12)
Current liabilities
Accounts payable	66,297	57,940
Accrued expenses and other current liabilities	390,007	374,278
Short-term lease liability	12,877	0
Related party debt, net	192,875	213,840
Deferred revenue	77,880	80,880
Line of credit	397,500	397,500
Notes payable	399,717	413,099
Note payable – other	50,000	50,000
Note payable - related party	170,000	170,000
Convertible notes- other	673,750	673,750
Total current liabilities	2,430,903	2,431,287
Long-term lease liability	29,160	0
TOTAL LIABILITIES	2,460,063	2,431,287
Common stock
Common Stock: $0.0001 par value; 3,000,000,000 shares authorized, 1,531,592,608 and 1,493,142,608 shares issued and outstanding as of September 30, 2022 and June 30, 2022, respectively	153,159	149,314
Common stock to be issued (76,610,000 and 35,602,500 shares as of September 30, 2022 and June 30, 2022, respectively)	713,500	407,677
Additional paid-in capital	37,270,452	36,773,035
Accumulated deficit	(40,172,149)	(39,423,382)
Total Shareholders’ Deficit	(2,033,909)	(2,092,227)
Total Liabilities and Shareholders’ Deficit	426,154	339,060
Series A Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	1	1
Series B Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	1	1
Series C Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	684	684
Series D Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	43	43
Series E Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	$ 400	$ 400

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Depreciation	$ 10,893	$ 8,349
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	25,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,531,592,608	1,493,142,608
Common stock, shares outstanding	1,531,592,608	1,493,142,608
Common stock to be issued	76,610,000	35,602,500
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	688	688
Preferred stock, shares outstanding	688	688
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	62,500	62,500
Preferred stock, shares issued	9,938	9,938
Preferred stock, shares outstanding	9,938	9,938
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	6,944,445	6,944,445
Preferred stock, shares issued	6,838,889	6,838,889
Preferred stock, shares outstanding	6,838,889	6,838,889
Series D Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	425,000	425,000
Preferred stock, shares outstanding	425,000	425,000
Series E Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	4,000,000	4,000,000
Preferred stock, shares outstanding	4,000,000	4,000,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 216,460	$ 302,872
Cost of sales	(120,002)	(203,511)
Gross profit	96,458	99,361
Operating expenses
Selling expense	190,010	148,079
Research and development expense	2,180	149,000
Depreciation expense	2,544	849
Consulting and professional fees	42,314	172,454
Insurance	29,192	15,917
Rent	5,410	4,455
Salaries and wages	502,856	3,529,453
Software expense		93,477
General and administrative	81,977	82,785
Total Operating expenses	856,483	4,196,469
Loss from operations	(760,025)	(4,097,108)
Other (income) / expense, net
Other income	(19,500)	0
Interest income	(1,500)	0
Change in fair value of derivative instrument	0	238,155
Gain on debt extinguishment	0	(15,832)
Interest expense	9,742	35,304
Total other (income) expense, net	(11,258)	257,627
Net loss before taxes	(748,767)	(4,354,735)
Income tax	0	0
Net loss	$ (748,767)	$ (4,354,735)

Consolidated Statements of Op_2

Consolidated Statements of Operations (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Earnings Per Share, Basic	$ (0.0005)	$ (0.0223)
Earnings Per Share, Diluted	$ (0.0005)	$ (0.0223)
Weighted Average Number of Shares Outstanding, Basic	1,517,790,978	195,378,542
Weighted Average Number of Shares Outstanding, Diluted	1,517,790,978	195,378,542

Consolidated Statements of Shar

Consolidated Statements of Shareholder's Deficit (Unaudited) - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Preferred Stock Series C [Member]	Series C To Be Issued [Member]	Preferred Stock Series D [Member]	Preferred Stock Series E [Member]	Series E To Be Issued [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
As at June 30, 2022 at Jun. 30, 2021	$ 1	$ 1	$ 684		$ 43	$ 190	$ 57,000	$ 64,708	$ 169,005	$ 22,732,295	$ (26,374,227)	$ (3,350,300)
Beginning balance, shares at Jun. 30, 2021	688	9,938	6,838,889		425,000	1,900,000	100,000	647,074,177	20,050,000
Loss for the period											(4,354,735)	(4,354,735)
Common stock for compensation								$ 700	$ 60,000	74,300		135,000
Common stock for compensation, shares								7,000,000	5,000,000
Common stock for debt conversion								$ 2,527		250,166		252,693
Common stock for debt conversion , shares								25,269,253
Issuance of Series C Preferred shares
Return of preferred stock
Preferred stock issued/officer comp
Common stock issued/officer comp
Common stock for officer compensation									$ 2,498			2,498
Common stock for officer compensation, shares									225,000
Preferred stock for compensation						200				2,999,800		3,000,000
Preferred stock for compensation, shares						2,000,000
Shares sold for cash								$ 23,250	$ (100,000)	2,301,750		2,225,000
Shares sold for cash, shares								232,500,000	(10,000,000)
As at September 30, 2022 at Sep. 30, 2021	$ 1	$ 1	$ 684		$ 43	$ 390	$ 57,000	$ 91,184	$ 131,503	28,358,311	(30,728,961)	(2,089,845)
Ending balance, shares at Sep. 30, 2021	688	9,938	6,838,889		425,000	3,900,000	100,000	911,843,430	15,275,000
As at June 30, 2022 at Jun. 30, 2021	$ 1	$ 1	$ 684		$ 43	$ 190	$ 57,000	$ 64,708	$ 169,005	22,732,295	(26,374,227)	(3,350,300)
Beginning balance, shares at Jun. 30, 2021	688	9,938	6,838,889		425,000	1,900,000	100,000	647,074,177	20,050,000
As at September 30, 2022 at Jun. 30, 2022	$ 1	$ 1	$ 684		$ 43	$ 400		$ 149,314	$ 407,677	36,773,035	(39,423,382)	(2,092,227)
Ending balance, shares at Jun. 30, 2022	688	9,938	6,838,889		425,000	4,000,000		1,493,142,608	35,602,500
Loss for the period											(748,767)	(748,767)
Common stock for compensation								$ 500	$ (30,000)	65,500		36,000
Common stock for compensation, shares								5,000,000	(2,000,000)
Common stock to be issued for compensation									$ 441			441
Common stock to be issued for compensation, shares									32,500
Common stock to be issued for officer comp									$ 47,144			47,144
Common stock to be issued for officer comp, shares									3,475,000
Common stock for officer compensation								$ 695	$ (101,262)	100,567
Common stock for officer compensation, shares								6,950,000	(6,950,000)
Shares issued for services								$ 500		88,500		89,000
Shares issued for services, shares								5,000,000
Shares sold for cash - prior quarter								$ 2,150	$ (215,000)	212,850
Shares sold for cash - prior quarter, shares								21,500,000	(21,500,000)
Shares sold for cash - current quarter									$ 604,500			604,500
Shares sold for cash - current quarter, shares									67,950,000
Payment of subscription receivable										30,000		30,000
As at September 30, 2022 at Sep. 30, 2022	$ 1	$ 1	$ 684		$ 43	$ 400		$ 153,159	$ 713,500	$ 37,270,452	$ (40,172,149)	$ (2,033,909)
Ending balance, shares at Sep. 30, 2022	688	9,938	6,838,889		425,000	4,000,000		1,531,592,608	76,610,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flow from operating activities
Net loss	$ (748,767)	$ (4,354,735)
Adjustment for non-cash charges and other items:
Depreciation	2,544	849
Stock compensation expense	172,585	3,137,498
Change in fair value of derivative instrument	0	238,155
Gain on debt extinguishment	0	(15,832)
Total adjustments	(573,638)	(994,065)
Changes in working capital
Decrease / (increase) in accounts receivable	(16,657)	25,694
Decrease / (increase) in inventory	(34,132)	0
Decrease / (increase) in prepaid inventory	43,518	22,682
Decrease / (increase) in prepaid expenses	(1,325)	(49,600)
(Decrease) / increase in trade and other payables	8,357	(31,385)
(Decrease) / increase in accrued expenses	15,765	27,344
(Decrease) / increase in deferred revenue	(3,000)	(1,542)
Total changes in working capital	12,526	(6,807)
Cash flow used in operating activities	(561,112)	(1,000,872)
Cash flow from investing activities
Purchases of property and equipment	(9,442)	(50,000)
Cash flow used in investing activities	(9,442)	(50,000)
Cash flow from financing activities
Proceeds from issuance of stock for cash	634,500	2,225,000
Advances from related party	0	29,705
Proceeds received from related parties	155,800	0
Payments to related parties	(20,965)	0
Proceeds from note payable	0	20,000
Repayments of note payable	(13,382)	(318,468)
Cash flow provided by financing activities	755,953	1,956,237
Increase in cash and cash equivalents	185,399	905,365
Cash and cash equivalents at beginning of the year	70,505	847,430
Cash and cash equivalents at end of the year	255,904	1,752,795
Non-cash investing and financing activities
Write off of derivative liability due to debt conversion	0	176,800
Issuance of common stock for conversion of notes payable and conversion fees	0	7,225
Interest	0	0
Taxes	$ 0	$ 0

Nature and Continuance of Opera

Nature and Continuance of Operations	3 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature and Continuance of Operations	Note 1 – Nature and Continuance of Operations Wearable Healthcare Solutions Inc. (the Company) was incorporated as Medical Alarm Concepts Holding, Inc. on June 4, 2008, under the laws of the State of Nevada. The Company was formed for the sole purpose of acquiring all of the membership units of Medical Alarm Concepts LLC, a Pennsylvania limited liability company (“Medical LLC”). On May 26, 2016, the Company filed an Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to change its name from “Medical Alarm Concepts, Inc.” to “Wearable Health Solutions, Inc.” The Company provides mobile health (mHealth) products and services to be used by customers in case of an emergency. As a provider of personal emergency devices, the Company provides innovative wearable healthcare products, tracking services, and turn-key solutions that enable our users to be proactive with their health, as well as safe and protected. The Company’s flagship products are the iHelp devices, the 3G and the next generation iHelp MAX™ – personal emergency alarm that are used to summon help in the event of an emergency at home. Basis of presentation The accompanying interim condensed consolidated financial statements are unaudited, but in the opinion of the Company’s management, contain all adjustments, which include normal recurring adjustments, necessary to present fairly the financial position at September 30, 2022, and the results of operations, the changes in shareholders’ deficit and cash flows for the three months ended September 30, 2022. The balance sheet as of June 30, 2022, is derived from the Company’s audited consolidated financial statements. Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although management of the Company believes that the disclosures contained in these consolidated financial statements are adequate to make the information presented therein not misleading. For further information, refer to the consolidated financial statements and the notes thereto included in the Company’s Annual Report on the Form 10-K for the fiscal year ended June 30, 2022. The results of operations for the three months ended September 30, 2022, are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2023.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Use of Estimates The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements. Principles of Consolidation Cash and Cash Equivalents Accounts Receivable 16,657 0 23,705 0 Software Development for internal use 50,000 5 Concentration of Credit Risk Recognition of Revenues Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues at a point in time when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues over the term of the service contract and when the services are rendered. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues, and records the balance of revenues as they become current. Schedule of revenues 3 months ended September 30, 2022 2021 REVENUES Hardware revenue $ 26,876 $ 53,583 Service revenue 189,584 249,289 TOTAL REVENUES $ 216,460 $ 302,872 The following table discloses changes in deferred revenue for the three months ended September 30, 2022 and 2021: Revenues (Details - Deferred revenue) DEFERRED REVENUE 2022 2021 Balance at beginning of period $ 80,880 $ 108,298 Deferred revenue recognized upon shipments to customers 47,422 2,682 Revenues recognized to end customers (50,422 ) (4,224 ) Balance at the end of the period $ 77,880 $ 106,756 Deferred revenue at September 30, 2022 and 2021 was $ 77,880 106,756 Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2021, 2020, and 2019 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed. Fair value of financial instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards. Research and Development 2,180 149,000 Basic and Diluted Loss per Common Share - Schedule of anti-dilutive shares Basis of conversion Dilution 2022 2021 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 and 3,900,000 shares outstanding in 2022 and 2021, respectively 1 share E: 100 shares 400,000,000 390,000,000 Series E Convertible -0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively 1 share E: 100 shares – 10,000,000 472,660,142 472,660,142 The Company has incurred losses for the past two years, as a result, the basic and diluted share bases will be presented as the same. For the three month periods ended September 30, 2022 and 2021, the Company incurred losses of ($0.0005) and ($0.0223) per basic share and diluted share, respectively. Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes. The update is intended to simplify the current rules regarding the accounting for income taxes and addresses several technical topics including accounting for franchise taxes, allocating income taxes between a loss in continuing operations and in other categories such as discontinued operations, reporting income taxes for legal entities that are not subject to income taxes, and interim accounting for enacted changes in tax laws. The new standard is effective for fiscal years beginning after December 15, 2020; however, early adoption is permitted. The Company does not expect the adoption of this standard have a material impact on the consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from shareholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or modified retrospective basis. The Company is currently evaluating the timing, method of adoption and overall impact of this standard on its consolidated financial statements. The Company reviewed all recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC, and they did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Going Concern

Going Concern	3 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern The accompanying consolidated financial statements for the three months ended September 30, 2022 and 2021 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As at September 30, 2022 and June 30, 2022, the Company has shown losses for the last two years and has an accumulated deficit of ($ 40,172,149 39,423,382 During the three months ended September 30, 2022, Company has net cash used in operating activities of $ 561,112 172,585 748,767 755,953 2,095,299 Management believes that the Company’s capital requirements will depend on many factors including the success of the Company’s development efforts and its efforts to raise capital. Management also believes the Company needs to raise additional capital for working capital purposes. There can be no assurance that the Company will be able to obtain the additional capital resources necessary to implement its business plan or that any assumptions relating to its business plan will prove accurate. These factors raise substantial doubt about our ability to continue as a going concern for a period of 12 months from the issue date of this report. The consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Inventory and prepaid expenses

Inventory and prepaid expenses	3 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventory and prepaid expenses	Note 4 – Inventory and prepaid expenses The Company maintains some inventory in its warehouse and purchases some of its inventory overseas. Inventories, except for stock in transit, are stated at lower of cost and net realizable value. Stock in transit is valued at cost comprising invoice value plus other charges thereon. Net realizable value is the estimated selling price in ordinary course of business less estimated costs of completion and selling expenses. The quantity of inventory may vary from time to time depending on the delivery schedule of overseas shipments. As of September 30, 2022 and June 30, 2022, the Company had $ 41,196 7,064 18,522 62,040 As of September 30, 2022 and June 30, 2022, the Company had $ 1,325 0

Property and Equipment

Property and Equipment	3 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 5 – Property and Equipment The Company has $20,000 in furnishings, $19,689 in office computers and equipment, and capitalized software development costs of $45,900 which are fully depreciated. On August 30, 2021, the Company purchased its dealer portal for $50,000 for internal use, and is being depreciated over 60 months. As of September 30, 2022 and June 30, 2022, the Company recorded $ 48,549 41,651 Schedule of property, plant and equipment September 30, June 30, 2022 2022 Furniture $ 29,442 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer Portal 50,000 50,000 Property, plant, and equipment 145,031 135,589 Less accumulated depreciation (96,482 ) (93,938 ) Net property, plant, and equipment $ 48,549 $ 41,651

Accounts payable and accrued ex

Accounts payable and accrued expenses and other current liabilities	3 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accounts payable and accrued expenses and other current liabilities	Note 6 – Accounts payable and accrued expenses and other current liabilities The Company recorded Accounts Payable of $ 66,297 57,940 Accrued expenses and other current liabilities are expenses that have been incurred but not yet paid, mainly include legal fees, audit fees and other professional fees as well as accrued interest in connection with the credit line and notes payable. The Company recorded $ 402,884 374,278

Notes Payable and Note Payable

Notes Payable and Note Payable - Other	3 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Notes Payable and Note Payable - Other	Note 7 – Notes Payable and Note Payable - Other Notes payable consists of notes payable from our subsidiary, notes payable-other, convertible notes payable, notes payable for stock purchases under Reg A, short term notes payable, and notes payable-BOAPIN portal, as follows: Schedule of short term notes payable September 30, 2022 June 30, 2022 Notes from subsidiary $ 160,861 $ 174,243 Notes payable – Reg A deposits 138,856 138,856 Short term bridge loan 100,000 100,000 Total Notes Payable $ 399,717 $ 413,099 Notes Payable - subsidiary The Company has various loans and credit lines outstanding. The credit line carries an interest rate of 6.24 9.24 10.90 Schedule of notes payable September 30, 2022 June 30, 2021 Wells Fargo Loan $ 8,770 $ 8,770 On Deck Loan 139,569 139,569 Susquehanna Salt Loan – 10,500 Prosper Loans 9,994 9,994 Marcus Loan 2,528 5,410 Total Notes from Subsidiary (See Table Above) $ 160,861 $ 174,243 Short term bridge loan - COHEN On July 31, 2020, the Company secured a $ 500,000 12 12 On August 19, 2021, the Company repaid $ 300,000 100,000 At September 30, 2022 and June 30, 2022, the Company recorded a short term note payable of $ 100,000 3,000 10,981 79,677 76,677 Note payable – stock purchases under Reg A In March 2021 and June 2021, the Company accepted payments of $ 115,000 20,000 In October 2021, the Company accepted a loan of $ 5,000 At September 30, 2022 and June 30, 2022, the Company has recorded $ 138,856 138,856 2,700 2,300 13,494 10,794 Note Payable – Other In November, 2016, the Company secured a $ 50,000 4 1,000,000 4 During the three months ended September 30, 2022 and September 30, 2021, the Company recorded interest expense of $ 500 500 11,782 11,282 Convertible note payable – BENZA, D2CF On March 1, 2016 and March 3, 2016, the Company closed a private placement of debt and received an aggregate of $ 612,500 13,750 660,000 The Company is currently in negotiations to settle the $ 660,000 As of September 30, 2022 and June 30, 2022, the Company reported $ 673,750 673,750 Credit line – MediPendant New York Inc. On September 30, 2014, our subsidiary entered into a line of credit with Medi Pendant New York, Inc. (“MNY”), which is partially owned by a principal of its subsidiary. Under the line of credit agreement, the Company will be able to borrow up to $ 500,000 6.5 September 30, 2017 500,000 200,000 28,000 As of September 30, 2022 and June 30, 2022, the Company has recorded $ 397,500 397,500 Debt settlement – On Deck, Susquehanna, MCA Cure In 2019, our subsidiary engaged MCA CURE to negotiate settlements with two creditors: On Deck and Susquehanna Salt, noted in the table above. The Company ceased paying the loan payments and paid to MCA Cure $ 43,875 47,000 90,875 0 0 139,569 139,569 0 10,500

Stockholders_ Deficit

Stockholders’ Deficit	3 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders’ Deficit	Note 10 – Stockholders’ Deficit Preferred Stock: The Company is currently authorized to issue 25,000,000 0.0001 Series A Convertible Preferred Stock 100,000 0.0001 688 Series B Convertible Preferred Stock 62,500 0.0001 9,938 Series C Convertible Preferred Stock 6,944,445 0.0001 The Company issued 6,700,003 6,838,889 Series D Convertible Preferred Stock : 500,000 0.0001 425,000 Series E Convertible Preferred Stock : 4,000,000 0.0001 Each of these shares carries a voting right equivalent to 10,000 shares of common stock. During the year ended June 30, 2021, as part of the change in control, 4,000,000 1,000,000 450,000 900,000 513,000 0.57 100,000 57,000 1,000,000 3,000,000 As of September 30, 2022 and June 30, 2022, 4,000,000 4,000,000 Common Stock The Company is currently authorized to issue 3,000,000,000 0.0001 During the three months ended September 30, 2022, the Company issued 6,950,000 101,262 5,000,000 66,000 21,500,000 215,000 5,000,000 89,000 During the three months ended September 30, 2022, the Company also recorded shares to be issued of 3,475,000 47,144 32,500 441 During August and September 2022, the Company received proceeds totaling $ 604,500 67,950,000 300,000 37,500,000 0.008 304,500 30,450,000 0.01 For the three months ended September 30, 2021, the Company issued 7,000,000 75,000 .0107 5,000,000 52,500 As of September 30, 2022 and June 30, 2022, the Company has 1,531,592,608 1,493,142,608

Related Party Transactions

Related Party Transactions	3 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 11 – Related Party Transactions Note payable – BOAPIN purchase In August 2020, and effective as of June 30, 2020, the Company purchased the BOAPIN portal, including all software, licensing, and ownership rights from Hypersoft Ventures, Inc., a related party through common ownership, for $800,200, which includes six million seven hundred thousand three (6,700,003) shares of Series C Convertible Preferred stock, valued at $375,200 or $0.056 per share, based on the conversion of one share of Series C Preferred stock for 10 shares of common stock and the stock price on the date of the transaction, and a note payable for $425,000, bearing eight percent (8%) interest with no prepayment or delinquency clauses. As of September 30, 2022 and June 30, 2022, the Company has recorded a Note payable-BOAPIN of $ 170,000 170,000 3,428 8,570 52,843 49,415 Related party debt, net From time to time, the Company received funds from related parties for day-to-day operations. These are short-term loans which bear no interest, and the Company expects to repay these loans by the end of the fiscal year following the year in which the short-term loan was made. The following table reflects the composition of the related party debt, net balance at September 30, 2022 and June 30, 2022. The Company had a receivable from certain management employees totaling $155,800 at June 30, 2022. The total receivable balance was subsequently collected by the Company on September 27, 2022. Schedule of related party transactions September 30, June 30, 2022 2022 Related parties – subsidiary $ 192,875 $ 202,875 Due from related parties – (155,800 ) Accrued salaries, bonus, fees – 10,965 Total loans from related parties, net $ 192,875 $ 58,040

Commitments and contingencies

Commitments and contingencies	3 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Note 12 – Commitments and contingencies Legal Matters From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. 1) Wearable Health Solutions, Inc. v. Barry Honig, GRQ Consultants Inc., Benza Pharma LLC and John Does 1-10, Supreme Court of the State of New York County of New York, July 22, 2021. Company is disputing the validity of Notes from 3/2016 and seeking damages, reparations, and related costs. 2) GRQ Consultants, Inc. v. Wearable Health Solutions, Inc., Supreme Court of the State of New York, County of New York, August 26, 2021, Parties are seeking summary judgment of $50,000 plus accrued interest in response to lawsuit by Company regarding $50,000 loan from 11/2016. 3) Benza Pharma LLC, Sandor Capital, LP, and John Lema v. Wearable Health Solutions, Inc., District Court, Clark County, Nevada, Parties are seeking summary judgment of $3,000,000 plus accrued interest in regards to convertible notes payable from March, 2016. The Company believes that there is a very low probability that it will pay this amount and as a result has not accrued for it on the Company’s balance sheet. 4) Medical Alarm Concepts LLC v. MCA Cure, LLC, Superior Court of New Jersey, Law Division, Morris County. Company is seeking return of payments for non-performance plus attorney fees and court costs. A settlement was reached between the parties whereby MCA Cure will pay an initial $10,000 and $6,500 each month until debt is satisfied in 2023 (See Note 13). Commitments and Contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

Office_Warehouse lease

Office/Warehouse lease	3 Months Ended
	Sep. 30, 2022
Officewarehouse Lease
Office/Warehouse lease	Note 13 – Office/Warehouse lease In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the current accounting for leases and while retaining two distinct types of leases, finance and operating, (1) requires lessees to record a right of use asset and a related liability for the rights and obligations associated with a lease, regardless of lease classification, and recognize lease expense in a manner similar to current accounting, (2) eliminates most real estate specific lease provisions, and (3) aligns many of the underlying lessor model principles with those in the new revenue standard. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. For public companies, the new standard is effective for annual and interim periods in fiscal years beginning after December 15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 2020. The Company maintains its corporate office at 2901 W. Coast Highway, Suite 200, Newport Beach, CA 92663. The Company currently pays $175 a month for its office space and the term is month-to-month. The Company’s subsidiary maintains a warehouse office in Pennsylvania to facilitate inventory arrival and product shipment. The three-year lease at $1,100 per month expired on September 30, 2021, and was renewed for 12 months at $1,300 per month beginning October 1, 2021 and expiring on September 30, 2022. Schedule lease cost 2022 2021 Rent expense $ 5,410 $ 3,300 The Company leases a fulfillment center in the U.S., which is classified as an operating lease which expired on September 30, 2022. The Company determines if an arrangement qualifies as a lease at the lease inception. Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate leases, which are for a fulfillment center, generally have a lease term between 3 5 The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company utilizes its incremental borrowing rate by lease term, in order to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis, and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams commensurate with the lease term. The Company’s lease agreement for its warehouse space located in King of Prussia, Pennsylvania expired on September 30, 2022. The Company is currently in a month-to-month arrangement with the warehouse located in King of Prussia, Pennsylvania. As a result, the Company entered into a new three-year lease agreement on September 9, 2022 for new warehouse space located in Mequon, Wisconsin. The monthly rent which commenced in September 2022 is $1,325 per month and increases approximately 3% annually thereafter. The discount rate used was determined based on the available data as of the lease commencement date. The Right-of-use (“ROU”) asset value added as a result of this new lease agreement was $ 43,058 Certain of the Company’s lease agreements, primarily related to real estate, include options for the Company to either renew (extend) or early terminate the lease. Leases with renewal options allow the Company to extend the lease term typically between 1 and 3 years. Renewal options are reviewed at lease commencement to determine if such options are reasonably certain of being exercised, which could impact the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several factors, including but not limited to, significance of leasehold improvements incurred on the property, whether the asset is difficult to replace, or specific characteristics unique to the particular lease that would make it reasonably certain that the Company would exercise such option. In most cases, the Company has concluded that renewal and early termination options are not reasonably certain of being exercised by the Company (and thus not included in the Company’s ROU asset and lease liability) unless there is an economic, financial or business reason to do so. For the three months ended September 30, 2022, total operating lease cost was $ 5,410 Schedule of future lease payments Fiscal Year Ending June 30, 2023 $ 11,925 2024 16,250 2025 16,670 July & August 2025 2,790 Total future minimum lease payments 47,635 Less imputed interest (5,598 ) Total present value of future minimum lease payments $ 42,037 Schedule of balance sheet related leases As of September 30, 2022 Operating lease right-of-use assets $ 42,001 Accrued lease liability 12,877 Long-term lease liability 29,160 $ 42,037 As of September 30, 2022 Weighted Average Remaining Lease Term 2.9 Weighted Average Discount Rate 8.44

Other income - settlement

Other income - settlement	3 Months Ended
	Sep. 30, 2022
Other Income and Expenses [Abstract]
Other income - settlement	Note 14 – Other income - settlement Settlement In 2019, the Company engaged MCA Cure to negotiate settlements with two note holders, and paid MCA Cure a total of $97,625. In 2020, the Company discovered MCA Cure had not performed when bank accounts were levied for $33,705 and $18,705, being subsequently refunded, and engaged an attorney to recover funds. Currently the Company has a settlement agreement in place with Susquehanna Salt Loan and has hired an attorney to recover funds and damages from MCA Cure. In February 2022, a settlement was reached with MCA Cure for fees and attorney costs of $ 105,125 For the three months ended September 30, 2022 and 2021, the Company recorded $ 19,500 0

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 15 – Subsequent Events The Company evaluated events that have occurred after the balance sheet date but before the financial statements are issued and determined that there are no material events that are required to be disclosed.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements.
Principles of Consolidation	Principles of Consolidation
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable 16,657 0 23,705 0
Software Development for internal use	Software Development for internal use 50,000 5
Concentration of Credit Risk	Concentration of Credit Risk
Recognition of Revenues	Recognition of Revenues Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues at a point in time when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues over the term of the service contract and when the services are rendered. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues, and records the balance of revenues as they become current. Schedule of revenues 3 months ended September 30, 2022 2021 REVENUES Hardware revenue $ 26,876 $ 53,583 Service revenue 189,584 249,289 TOTAL REVENUES $ 216,460 $ 302,872 The following table discloses changes in deferred revenue for the three months ended September 30, 2022 and 2021: Revenues (Details - Deferred revenue) DEFERRED REVENUE 2022 2021 Balance at beginning of period $ 80,880 $ 108,298 Deferred revenue recognized upon shipments to customers 47,422 2,682 Revenues recognized to end customers (50,422 ) (4,224 ) Balance at the end of the period $ 77,880 $ 106,756 Deferred revenue at September 30, 2022 and 2021 was $ 77,880 106,756
Deferred Taxes	Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2021, 2020, and 2019 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed.
Fair value of financial instruments	Fair value of financial instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards.
Research and Development	Research and Development 2,180 149,000
Basic and Diluted Loss per Common Share	Basic and Diluted Loss per Common Share - Schedule of anti-dilutive shares Basis of conversion Dilution 2022 2021 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 and 3,900,000 shares outstanding in 2022 and 2021, respectively 1 share E: 100 shares 400,000,000 390,000,000 Series E Convertible -0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively 1 share E: 100 shares – 10,000,000 472,660,142 472,660,142 The Company has incurred losses for the past two years, as a result, the basic and diluted share bases will be presented as the same. For the three month periods ended September 30, 2022 and 2021, the Company incurred losses of ($0.0005) and ($0.0223) per basic share and diluted share, respectively.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes. The update is intended to simplify the current rules regarding the accounting for income taxes and addresses several technical topics including accounting for franchise taxes, allocating income taxes between a loss in continuing operations and in other categories such as discontinued operations, reporting income taxes for legal entities that are not subject to income taxes, and interim accounting for enacted changes in tax laws. The new standard is effective for fiscal years beginning after December 15, 2020; however, early adoption is permitted. The Company does not expect the adoption of this standard have a material impact on the consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from shareholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or modified retrospective basis. The Company is currently evaluating the timing, method of adoption and overall impact of this standard on its consolidated financial statements. The Company reviewed all recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC, and they did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of revenues	Schedule of revenues 3 months ended September 30, 2022 2021 REVENUES Hardware revenue $ 26,876 $ 53,583 Service revenue 189,584 249,289 TOTAL REVENUES $ 216,460 $ 302,872
Revenues (Details - Deferred revenue)	Revenues (Details - Deferred revenue) DEFERRED REVENUE 2022 2021 Balance at beginning of period $ 80,880 $ 108,298 Deferred revenue recognized upon shipments to customers 47,422 2,682 Revenues recognized to end customers (50,422 ) (4,224 ) Balance at the end of the period $ 77,880 $ 106,756
Schedule of anti-dilutive shares	Schedule of anti-dilutive shares Basis of conversion Dilution 2022 2021 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 and 3,900,000 shares outstanding in 2022 and 2021, respectively 1 share E: 100 shares 400,000,000 390,000,000 Series E Convertible -0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively 1 share E: 100 shares – 10,000,000 472,660,142 472,660,142

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment	Schedule of property, plant and equipment September 30, June 30, 2022 2022 Furniture $ 29,442 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer Portal 50,000 50,000 Property, plant, and equipment 145,031 135,589 Less accumulated depreciation (96,482 ) (93,938 ) Net property, plant, and equipment $ 48,549 $ 41,651

Notes Payable and Note Payabl_2

Notes Payable and Note Payable - Other (Tables)	3 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of short term notes payable	Schedule of short term notes payable September 30, 2022 June 30, 2022 Notes from subsidiary $ 160,861 $ 174,243 Notes payable – Reg A deposits 138,856 138,856 Short term bridge loan 100,000 100,000 Total Notes Payable $ 399,717 $ 413,099
Schedule of notes payable	Schedule of notes payable September 30, 2022 June 30, 2021 Wells Fargo Loan $ 8,770 $ 8,770 On Deck Loan 139,569 139,569 Susquehanna Salt Loan – 10,500 Prosper Loans 9,994 9,994 Marcus Loan 2,528 5,410 Total Notes from Subsidiary (See Table Above) $ 160,861 $ 174,243

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Schedule of related party transactions	Schedule of related party transactions September 30, June 30, 2022 2022 Related parties – subsidiary $ 192,875 $ 202,875 Due from related parties – (155,800 ) Accrued salaries, bonus, fees – 10,965 Total loans from related parties, net $ 192,875 $ 58,040

Office_Warehouse lease (Tables)

Office/Warehouse lease (Tables)	3 Months Ended
	Sep. 30, 2022
Officewarehouse Lease
Schedule lease cost	Schedule lease cost 2022 2021 Rent expense $ 5,410 $ 3,300
Schedule of future lease payments	Schedule of future lease payments Fiscal Year Ending June 30, 2023 $ 11,925 2024 16,250 2025 16,670 July & August 2025 2,790 Total future minimum lease payments 47,635 Less imputed interest (5,598 ) Total present value of future minimum lease payments $ 42,037
Schedule of balance sheet related leases	Schedule of balance sheet related leases As of September 30, 2022 Operating lease right-of-use assets $ 42,001 Accrued lease liability 12,877 Long-term lease liability 29,160 $ 42,037 As of September 30, 2022 Weighted Average Remaining Lease Term 2.9 Weighted Average Discount Rate 8.44

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details - Schedule of Revenues) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Product Information [Line Items]
Revenues	$ 216,460	$ 302,872
Hardware Revenue [Member]
Product Information [Line Items]
Revenues	26,876	53,583
Service Revenue [Member]
Product Information [Line Items]
Revenues	$ 189,584	$ 249,289

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details - Deferred revenue) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Accounting Policies [Abstract]
Balance at beginning of period	$ 80,880	$ 108,298
Deferred revenue recognized upon shipments to customers	47,422	2,682
Revenues recognized to end customers	(50,422)	(4,224)
Balance at the end of the period	$ 77,880	$ 106,756

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details - Antidilutive information) - shares	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
AntiDilutive Shares	472,660,142	472,660,142
Series A Preferred Stock [Member]
AntiDilutive Shares	1,376	1,376
Series B Preferred Stock [Member]
AntiDilutive Shares	19,876	19,876
Series C Preferred Stock [Member]
AntiDilutive Shares	68,388,890	68,388,890
Series D Preferred Stock [Member]
AntiDilutive Shares	4,250,000	4,250,000
Series E Preferred Stock [Member]
AntiDilutive Shares	400,000,000	390,000,000
Series E Preferred Stock To Be Issued [Member]
AntiDilutive Shares	0	10,000,000
Series A Convertible Stock [Member]
Basis of conversion	688 shares outstanding
Dilution	1 share A: 2 shares
Series B Convertible Stock [Member]
Basis of conversion	9,938 shares outstanding
Dilution	1 share B: 2 shares
Series C Convertible Stock [Member]
Basis of conversion	6,838,889 shares outstanding
Dilution	1 share C: 10 shares
Series D Convertible Stock [Member]
Basis of conversion	425,000 shares outstanding
Dilution	1 share D: 10 shares
Series E Convertible Stock [Member]
Basis of conversion	4,000,000 and 3,900,000 shares outstanding in 2022 and 2021, respectively
Dilution	1 share E: 100 shares
Series E Convertible Shares To Be Issued [Member]
Basis of conversion	-0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively
Dilution	1 share E: 100 shares

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Aug. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Accounting Policies [Abstract]
Accounts receivable, net		$ 16,657		$ 0
Allowance for doubtful accounts		23,705		0
Purchase of dealer portal	$ 50,000
Depreciated years	5 years
Deferred revenue		77,880	$ 106,756	$ 80,880	$ 108,298
Research and Development Expense		$ 2,180	$ 149,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 40,172,149		$ 39,423,382
Net cash used in operating activities	561,112	$ 1,000,872
Stock compensation non-cash expenses	172,585	3,137,498
Net loss	748,767	4,354,735
Cash flow from financing activities	755,953	$ 1,956,237
Negative working capital	$ 2,095,299

Inventory and prepaid expenses

Inventory and prepaid expenses (Details Narrative) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventory, net	$ 41,196	$ 7,064
Prepaid inventories	18,522	62,040
Prepaid expenses	$ 1,325	$ 0

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 145,031	$ 135,589
Less accumulated depreciation	(96,482)	(93,938)
Net property, plant, and equipment	48,549	41,651
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	29,442	20,000
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	19,689	19,689
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	45,900	45,900
Dealer Portal [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 50,000	$ 50,000

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Other, Net	$ 48,549	$ 41,651

Accounts payable and accrued _2

Accounts payable and accrued expenses and other current liabilities (Details Narrative) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 66,297	$ 57,940
Accrued liabilities	$ 402,884	$ 374,278

Notes Payable and Note Payabl_3

Notes Payable and Note Payable - Other (Details - Schedule of short term notes) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Debt Disclosure [Abstract]
Notes from subsidiary	$ 160,861	$ 174,243
Notes payable – Reg A deposits	138,856	138,856
Short term bridge loan	100,000	100,000
Total Notes Payable	$ 399,717	$ 413,099

Notes Payable and Note Payabl_4

Notes Payable and Note Payable - Other (Details - Notes payable) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Debt Instrument [Line Items]
Notes Payable	$ 160,861	$ 174,243
Wells Fargo Loan [Member]
Debt Instrument [Line Items]
Notes Payable	8,770	8,770
On Deck Loan [Member]
Debt Instrument [Line Items]
Notes Payable	139,569	139,569
Susquehanna Salt Loan [Member]
Debt Instrument [Line Items]
Notes Payable	0	10,500
Prosper Loans [Member]
Debt Instrument [Line Items]
Notes Payable	9,994	9,994
M A R C U S Loan [Member]
Debt Instrument [Line Items]
Notes Payable	$ 2,528	$ 5,410

Notes Payable and Note Payabl_5

Notes Payable and Note Payable - Other (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

4 Months Ended

12 Months Ended

Nov. 30, 2021

Oct. 31, 2021

Jul. 31, 2021

Jul. 31, 2020

Jan. 31, 2015

Sep. 30, 2014

Sep. 30, 2022

Mar. 31, 2022

Sep. 30, 2021

Jun. 30, 2021

Dec. 31, 2020

Dec. 31, 2019

Jun. 30, 2022

Aug. 19, 2021

Sep. 30, 2020

Nov. 30, 2016

Mar. 31, 2016

Mar. 03, 2016

Mar. 01, 2016

Debt Instrument [Line Items]

Rate of interest

6.24%

Principle amount repaid

$ 300,000

Repayment of debt

$ 100,000

Short term notes payable

$ 100,000

$ 100,000

Interest and accrued interest liability

3,000

$ 10,981

Accrued interest payable

79,677

76,677

Notes payable

160,861

174,243

Interest Payable

52,843

49,415

Loan from related party

138,856

138,856

Interest rate

4%

Borrowed amount

$ 500,000

Maturity date

Sep. 30, 2017

Increased amount

$ 500,000

Issuance of shares value

89,000

Line of credit balance

397,500

397,500

MCA Cure [Member]

Debt Instrument [Line Items]

Loan payments

$ 47,000

$ 43,875

Reserve fund

$ 90,875

Medi Pendant New York Inc [Member]

Debt Instrument [Line Items]

Rate of interest

6.50%

Issuance of shares

200,000

Issuance of shares value

28,000

Notes Payable, Other Payables [Member]

Debt Instrument [Line Items]

Interest expense

500

Interest Payable

11,782

11,282

B2CF [Member]

Debt Instrument [Line Items]

Convertible notes

$ 13,750

BENZA [Member]

Debt Instrument [Line Items]

Convertible notes

$ 660,000

BENZA and D2CF [Member]

Debt Instrument [Line Items]

Convertible notes

673,750

673,750

MCA Cure [Member]

Debt Instrument [Line Items]

Notes payable

0

0

On Deck Loan [Member]

Debt Instrument [Line Items]

Notes payable

139,569

139,569

Susquehanna Salt Loan [Member]

Debt Instrument [Line Items]

Notes payable

0

10,500

Chief Executive Officer [Member]

Debt Instrument [Line Items]

Acquisition of convertible notes payable

$ 1,000,000

Two Unaffiliated Investors [Member]

Debt Instrument [Line Items]

Proceeds from Loans

$ 5,000

$ 20,000

Chief Executive Officer [Member]

Debt Instrument [Line Items]

Loan from related party

$ 50,000

Interest rate

4%

Regulation A Filing [Member]

Debt Instrument [Line Items]

Interest expense

2,700

$ 2,300

Regulation A Filing [Member] | Two Unaffiliated Investors [Member]

Debt Instrument [Line Items]

Accepted stock payment

$ 115,000

Notes payable

138,856

138,856

Interest Payable

$ 13,494

$ 10,794

Private Placement [Member]

Debt Instrument [Line Items]

Aggregate amount

$ 612,500

COHEN [Member]

Debt Instrument [Line Items]

Short term bridge loan

$ 500,000

Interest rate

12%

Accrue interest

12%

Minimum [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate During Period

9.24%

Maximum [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate During Period

10.90%

Stockholders_ Deficit (Details

Stockholders’ Deficit (Details Narrative) - USD ($)		1 Months Ended	2 Months Ended	3 Months Ended		12 Months Ended
	Sep. 02, 2020	Dec. 31, 2020	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Class of Stock [Line Items]
Preferred stock, shares authorized			25,000,000	25,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Shares issued for purchase of asset	6,700,003
Number of sahres canceled							4,000,000
Shares issued			7,000,000	7,000,000
Stock issued for services, value				$ 89,000
Common stock, shares authorized			3,000,000,000	3,000,000,000		3,000,000,000
Common stock, par value			$ 0.0001	$ 0.0001		$ 0.0001
Proceeds from common stock				$ 634,500	$ 2,225,000
Contractual bonuses				$ 75,000
Contractual bonus price per share				$ 0.0107
Accured shares			5,000,000	5,000,000
Bonus paid amount				$ 52,500
Common stock, shares issued			1,531,592,608	1,531,592,608		1,493,142,608
Common stock, shares outstanding			1,531,592,608	1,531,592,608		1,493,142,608
Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued			67,950,000
Proceeds from common stock			$ 604,500
Contract price			$ 0.008	$ 0.008
Common Stock 1 [Member]
Class of Stock [Line Items]
Number of shares issued			37,500,000
Proceeds from common stock			$ 300,000
Contract price			$ 0.01	$ 0.01
Common Stock 2 [Member]
Class of Stock [Line Items]
Number of shares issued			30,450,000
Proceeds from common stock			$ 304,500
Employee [Member]
Class of Stock [Line Items]
Stock issued for services, shares				5,000,000
Stock issued for services, value				$ 66,000
Employee 1 [Member]
Class of Stock [Line Items]
Stock issued for services, shares				32,500
Stock issued for services, value				$ 441
Series E Convertible Stock [Member]
Class of Stock [Line Items]
Number of shares issued		900,000
Number of shares issued, value		$ 513,000
Shares price		$ 0.57
Stock issued for services, shares		100,000
Stock issued for services, value		$ 57,000
Officer [Member]
Class of Stock [Line Items]
Stock issued for services, shares				6,950,000
Stock issued for services, value				$ 101,262
Investor [Member]
Class of Stock [Line Items]
Stock issued for services, shares				21,500,000
Stock issued for services, value				$ 215,000
Investors [Member]
Class of Stock [Line Items]
Stock issued for services, shares				5,000,000
Stock issued for services, value				$ 89,000
Officer 1 [Member]
Class of Stock [Line Items]
Stock issued for services, shares				3,475,000
Stock issued for services, value				$ 47,144
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			100,000	100,000		100,000
Preferred stock, par value			$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares issued			688	688		688
Preferred stock, shares outstanding			688	688		688
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			62,500	62,500		62,500
Preferred stock, par value			$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares issued			9,938	9,938		9,938
Preferred stock, shares outstanding			9,938	9,938		9,938
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			6,944,445	6,944,445		6,944,445
Preferred stock, par value			$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares issued			6,838,889	6,838,889		6,838,889
Preferred stock, shares outstanding			6,838,889	6,838,889		6,838,889
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			500,000	500,000		500,000
Preferred stock, par value			$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares issued			425,000	425,000		425,000
Preferred stock, shares outstanding			425,000	425,000		425,000
Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			4,000,000	4,000,000		4,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, shares issued			4,000,000	4,000,000		4,000,000
Preferred stock, shares outstanding			4,000,000	4,000,000		4,000,000
Common stock voting right				Each of these shares carries a voting right equivalent to 10,000 shares of common stock.
Shares issued		1,000,000
Series E Preferred Stock [Member] | Director 1 [Member]
Class of Stock [Line Items]
Stock issued for services, shares						1,000,000
Series E Preferred Stock [Member] | Director 2 [Member]
Class of Stock [Line Items]
Stock issued for services, shares						1,000,000
Series E Preferred Stock [Member] | Two Directors [Member]
Class of Stock [Line Items]
Stock issued for services, value						$ 3,000,000
Series E Preferred Stock [Member] | Two Director [Member]
Class of Stock [Line Items]
Shares issued		450,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Related Party Transactions [Abstract]
Related parties – subsidiary	$ 192,875	$ 202,875
Due from related parties	0	(155,800)
Accrued salaries, bonus, fees	0	10,965
Total loans from related parties, net	$ 192,875	$ 58,040

Related Party Transactions (D_2

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022
Related Party Transaction [Line Items]
Debt expensed	$ 3,428	$ 8,570
Accrued interest	52,843		$ 49,415
Boapin [Member]
Related Party Transaction [Line Items]
Note payable	$ 170,000		$ 170,000

Office_Warehouse lease (Details

Office/Warehouse lease (Details) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Officewarehouse Lease
Rent expense	$ 5,410	$ 3,300

Office_Warehouse lease (Detai_2

Office/Warehouse lease (Details 1)	Sep. 30, 2022 USD ($)
Officewarehouse Lease
2023	$ 11,925
2024	16,250
2025	16,670
July & August 2025	2,790
Total future minimum lease payments	47,635
Less imputed interest	(5,598)
Total present value of future minimum lease payments	$ 42,037

Office_Warehouse lease (Detai_3

Office/Warehouse lease (Details 2) - USD ($)	Sep. 30, 2022	Jun. 30, 2022
Officewarehouse Lease
Operating lease right-of-use assets	$ 42,001	$ 0
Accrued lease liability	12,877
Long-term lease liability	29,160	$ 0
Operating lease liability	$ 42,037
Weighted Average Remaining Lease Term	2 years 10 months 24 days
Weighted Average Discount Rate	8.44%

Office_Warehouse lease (Detai_4

Office/Warehouse lease (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2022	Jun. 30, 2022
Lessee, Operating Lease, Description	The Company currently pays $175 a month for its office space and the term is month-to-month. The Company’s subsidiary maintains a warehouse office in Pennsylvania to facilitate inventory arrival and product shipment. The three-year lease at $1,100 per month expired on September 30, 2021, and was renewed for 12 months at $1,300 per month beginning October 1, 2021 and expiring on September 30, 2022.
Right of use asset	$ 42,001	$ 0
Lease, Cost	5,410
New Lease Agreement [Member]
Right of use asset	$ 43,058
Minimum [Member]
Lease term	3 years
Maximum [Member]
Lease term	5 years

Other income - settlement (Deta

Other income - settlement (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Feb. 28, 2022
Other Income and Expenses [Abstract]
Attorney costs			$ 105,125
Settlement income	$ 19,500	$ 0